SCHEMBL7777129

SCHEMBL7777129

CN(C(=O)c1[nH]nc(-c2ccc(S(N)(=O)=O)cc2)c1-c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.42
PTGS1 P23219 4/20 0.42
TTK P33981 1/20 0.42
GPBAR1 Q8TDU6 3/20 0.41
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
CA12 O43570 3/20 0.40
CA9 Q16790 3/20 0.40
CYP3A4 P08684 2/20 0.40
CA4 P22748 2/20 0.40
CA7 P43166 2/20 0.40
MT-CO2 P00403 1/20 0.40
LMNA P02545 1/20 0.40
CA3 P07451 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA2B P18089 1/20 0.40
CA6 P23280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777075 0.91 PTGS2 (0.43) PTGS2PTGS1GPBAR1CYP3A4CYP1A1
SCHEMBL7779806 0.87 PTGS2 (0.46) PTGS2PTGS1TTKCA1CA2
SCHEMBL7773067 0.82 PTGS2 (0.47) PTGS2PTGS1TTKCA1CA2
SCHEMBL7772912 0.80 CA1 (0.52) PTGS2PTGS1TTKCA1CA2
SCHEMBL7779394 0.79 CA1 (0.54) PTGS2CA1CA2CA12CA9
SCHEMBL8179843 0.78 CA1 (0.55) PTGS2PTGS1TTKCA1CA2
SCHEMBL7777941 0.77 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL8177293 0.77 PTGS2 (0.43) PTGS2PTGS1TTKCA1CA2
SCHEMBL8174619 0.77 CA1 (0.46) PTGS2PTGS1TTKCA1CA2
SCHEMBL8632186 0.76 CA1 (0.51) PTGS2PTGS1TTKCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed